我要投票 雷氏在珍珠粉行业中的票数:163
· 外 推 电 报 ·
2025-02-24 12:06:55 星期一

【雷氏是哪个国家的品牌?】

雷氏是什么牌子?「雷氏」是 上海雷允上药业有限公司 旗下著名品牌。该品牌发源于上海,由创始人苏俊英在1998-11-13期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力雷氏品牌出海!通过在本页面挂载雷氏品牌的产品链接和联系邮箱,可以提高雷氏产品曝光!跨境电商爆单神器,目前只要100元/年哦~

百年老字号雷允上药店始建于苏州,发迹于上海,迄今已有近三百年历史。公元1734年(清雍正十二年)创始于苏州;1860年(清咸丰十年)设“申号”于上海新北门外,1934年设“北号”于河南北路天后宫桥(今河南路桥)北堍,1937年又设北号支店于静安寺路(今南京西路)。由于药店规模较大,资产雄厚,影响面广,早年就被国药同业公认为上海中药店“四大户"之一。中国改革开放以来,经资产重组,工商联手,今日上海雷允上药业雄风再现,成为中国中药行业的强者。雷允上药业历史渊源>>

上海雷允上药业有限公司是上药集团上海市药材有限公司为投资主体成立的集农工商、科工贸、产学研于一体的大型中药企业,历年被认定为上海市高新技术企业、上海市文明单位,是上海市第一批知识产权示范企业,旗下“雷氏”品牌被认定为中国驰名商标,并以20.8亿的品牌价值荣获中国500最具价值品牌称号。近年来,公司及其品牌先后获得中国百年中药老字号企业、最具价值的上海老商标、上海市出口名牌、上海市装备制造业与高新技术产业自主创新品牌、上海现代服务业百强等荣誉称号。

公司拥有严格的质量保证体系。从中药产业链源头GAP规范标准入手,严格原药材采购控制。拥有国家GMP规范要求的中药产业化制造基地,能生产20多个剂型500多个品种。拥有包括中药材、中成药、保健品和名贵参茸等在内的强大的专业营销网络,辐射全国,足迹遍及东南亚、北美、欧洲等地。雷允上连锁多年被评为最具影响力特许品牌。六神丸、雷氏珍菊降压片、雷氏炮天红酒等产品历年被评为上海市名牌产品,在海内外均享有较高的声誉。多年坚持开展社区健康服务,2006年赢得了“全国卫生进社区——相约健康社区行”社会公益奖。

公司传承“至诚至信,关爱生命”的企业追求,竭尽所能地致力于服务社会、造福人类的伟大事业,为弘扬祖国优秀中医药文化,为人类的健康贡献力量。

英文翻译:The century old drugstore under leiyunshang pharmaceutical was founded in Suzhou and started in Shanghai. It has a history of nearly 300 years. It was founded in Suzhou in 1734 (the 12th year of Yongzheng reign in the Qing Dynasty); in 1860 (the 10th year of Xianfeng reign in the Qing Dynasty), it was set up outside the new North Gate of Shanghai; in 1934, it was set up in the north end of hougongqiao (now Henan Road bridge), North Henan Road; in 1937, it was set up in Jingansi Road (now Nanjing West Road). Due to the large scale, strong assets and wide influence of drugstores, they have been recognized as one of the "four big families" of Shanghai Traditional Chinese medicine stores by the pharmaceutical industry in the early years. Since China's reform and opening up, through asset restructuring and joint efforts of industry and commerce, the pharmaceutical industry of Shanghai leiyunshang Pharmaceutical Co., Ltd. has reappeared today, becoming a strong player in the Chinese traditional medicine industry. The history of pharmaceutical industry under leiyunshang pharmaceutical & gt; & gt; Shanghai leiyunshang Pharmaceutical Co., Ltd. is a large-scale traditional Chinese medicine enterprise established by Shanghai Pharmaceutical Group Co., Ltd. as the main investor, integrating agriculture, industry and commerce, science, industry and trade, production, learning and research. It has been recognized as a high-tech enterprise in Shanghai and a civilized unit in Shanghai. It is the first batch of intellectual property demonstration enterprises in Shanghai. Its "Leishi" brand is recognized as a well-known trademark in China Won the title of China's 500 most valuable brand with a brand value of 2.08 billion. In recent years, the company and its brand have successively won the honorary titles of China's century old brand enterprise of traditional Chinese medicine, the most valuable old trademark of Shanghai, Shanghai Export famous brand, independent innovation brand of Shanghai equipment manufacturing industry and high-tech industry, and top 100 modern service industry of Shanghai. The company has a strict quality assurance system. Starting from the gap standard of the source of traditional Chinese medicine industry chain, strictly control the purchase of original Chinese medicine. It has the industrialization manufacturing base of traditional Chinese medicine required by the national GMP standard, and can produce more than 20 dosage forms and more than 500 varieties. It has a strong professional marketing network including traditional Chinese medicine, Chinese patent medicine, health care products and rare ginseng antler, covering the whole country, covering Southeast Asia, North America, Europe and other places. Leiyunshang chain has been rated as the most influential franchise brand for many years. Liushenwan, Zhenju hypotensive tablet and Baotian red wine have been rated as famous brand products in Shanghai over the years, enjoying a high reputation at home and abroad. In 2006, it won the social public welfare award of "national health into the community - meeting healthy communities". The company inherits the enterprise pursuit of "sincere and trustworthy, caring for life", devotes itself to the great cause of serving the society and benefiting the human as much as possible, promotes the excellent traditional Chinese medicine culture of the motherland and contributes to the health of human beings.

本文链接: https://www.waitui.com/brand/942bfee42.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

韩国财政刺激计划料将推高国债收益率,并令韩元承压

韩国希望通过财政刺激来解决经济放缓问题,料将给韩元带来压力,并可能在债市已在消化创纪录供给的情况下令收益率曲线趋陡。面对潜在的美国关税和本地戒严令事件的影响,韩国正在寻求刺激措施以帮助经济。在国会中占据多数席位的反对党最近提出了35万亿韩元(240亿美元)的支出建议,还有建议出售更多的债券来为支出提供资金。据分析师称,任何额外的供应都会推高债券收益率并使曲线变陡。实际供应量可能在未来几周内确定。(新浪财经)

7分钟前

华为内部知情人士:“塔界”与鸿蒙智行无关

针对近期网络上关于“华为近300人团队入驻阿维塔;阿维塔科技已完成了‘塔界’的商标注册,可能成为鸿蒙智行又一‘界’合作品牌。”等传闻,华为内部知情人士称:所谓阿维塔注册“塔界”,与鸿蒙智行无关。(第一财经)

7分钟前

A股三大指数午间休盘集体下跌,DeepSeek概念下挫

36氪获悉,A股三大指数午间休盘集体下跌;沪指跌0.11%,深成指跌0.02%,创业板指跌0.79%;DeepSeek、CPO概念、生物科技板块领跌,每日互动跌超13%,优刻得跌超11%,新易盛跌超5%,药明康德跌超4%;农业、地产、保险板块涨幅居前,朗源股份涨停,首开股份涨超8%,新华保险涨超3%。

7分钟前

绿城中国:拟要约购买本金总额约4.52亿美元两只2025年到期美元债

36氪获悉,绿城中国公告,宣布要约现金购买于2025年到期的4.465亿美元4.7%未偿付的优先票据中部分将于4月到期的本金总额约3.12亿美元票据,以及于2025年到期的2.945亿美元5.65%未偿付的优先票据中部分将于7月到期的本金总额约1.4亿美元。届时,这两只美元债未偿付本金额将分别为约1.34亿美元及1.55亿美元。

7分钟前

半日主力资金加仓汽车股,抛售电子股

主力资金早间净流入汽车、机械设备、建筑装饰、房地产等板块,净流出电子、传媒、银行、钢铁等板块。具体到个股来看,万丰奥威、科华数据、数据港获净流入14.7亿元、13.14亿元、10.05亿元。净流出方面,杭钢股份、浙数文化、宁德时代遭抛售10.78亿元、10.24亿元、8.64亿元。(第一财经)

7分钟前

本页详细列出关于gNPearl京润的品牌信息,含品牌所属公司介绍,gNPearl京润所处行业的品牌地位及优势。
咨询